https://www.selleckchem.com/pr....oducts/hg-9-91-01.ht
n and avoid unnecessary treatment. • Adjuvant therapy decision in colorectal cancer can be a challenge in medical oncology. • Radiomics models, derived from diagnostic CT, trained and validated in a two-center cohort, could predict recurrence in stage II and III colorectal cancer patients. • Identifying patients with a low risk of recurrence, these models could facilitate treatment optimization and avoid unnecessary treatment. To investigate clinical and CT factors associated with local resectability in patients with nonmetastatic pa
Like
Comment
Share
